The British Columbia Securities Commission is warning the public to “exercise extreme caution” in dealing with companies aggressively promoting products or initiatives to detect, cure or treat COVID-19.
The securities commission singled out Revive Therapeutics Ltd., which is currently promoting a potential cure to the virus in North America and Europe.
The pharmaceutical company is based in Ontario and listed on the Canadian Securities Exchange. “Germany’s Federal Financial Supervisory Authority has issued an investor alert about Revive, warning that buy recommendations are currently being made on a large scale in the form of market letters and e-mails,” a statement from the B.C.